ScholarIQanswers from OpenAlex & ORCID
Joseph P. Costantino
ResearcherPublications, citations & collaboration network
Joseph P. Costantino is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Joseph P. Costantino have?
ScholarIQindexed works
Joseph P. Costantino has 301 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Joseph P. Costantino have?
ScholarIQcitation count
Joseph P. Costantino has 43,254 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Joseph P. Costantino?
ScholarIQh-index
Joseph P. Costantino has an h-index of 81 in OpenAlex.
What is the i10-index of Joseph P. Costantino?
ScholarIQi10-index
Joseph P. Costantino has an i10-index of 175 in OpenAlex.
What is the OpenAlex record for Joseph P. Costantino?
ScholarIQopenalex
The OpenAlex for Joseph P. Costantino is on the source record.
What are the most-cited papers on Joseph P. Costantino?
ScholarIQmost cited works
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Joseph P. Costantino, Takamaru Ashikaga, Donald L. Weaver, Eleftherios P. Mamounas, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Norman Wolmark
Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer
Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer